02976nas a2200457 4500000000100000008004100001260002300042653001800065653001700083100001300100700001300113700001300126700001300139700001300152700001600165700001500181700001400196700001400210700001200224700001100236700001300247700001300260700001400273700001500287700001300302700001400315700001600329700001100345700001300356700001400369700001100383700001300394700001200407700001500419700002000434245019500454856009900649300000800748520173700756022002502493 2022 d bInforma UK Limited10aOphthalmology10aEpidemiology1 aMiecha H1 aDejene M1 aAdugna D1 aKebede A1 aYadeta D1 aAlemayehu A1 aAbateneh A1 aWondimu A1 aDayessa M1 aShafi M1 aTaye E1 aBalcha L1 aGadisa S1 aNegussu N1 aMengistu B1 aWillis R1 aJimenez C1 aBakhtiari A1 aBoyd S1 aKebede B1 aTadesse F1 aMamo A1 aBekele M1 aSinke Z1 aSolomon AW1 aHarding-Esch EM00aPrevalence of Trachoma after Implementation of Trachoma Elimination Interventions in Oromia Regional State, Ethiopia: Results of Impact Surveys in 131 Evaluation Units Covering 139 Districts uhttps://www.tandfonline.com/doi/epdf/10.1080/09286586.2022.2119257?needAccess=true&role=button a1-83 a

Purpose
To determine the prevalence of trachomatous inflammation—follicular (TF), trachomatous trichiasis (TT), water, sanitation, and hygiene (WASH) access in 131 evaluation units (EUs) after implementation of trachoma elimination interventions in Oromia Region, Ethiopia.

Methodology
A population-based cross-sectional survey was conducted in each EU using the World Health Organization-recommended two-stage cluster-sampling methodology. Twenty-six clusters, each with a mean of 30 households were enumerated in each EU. All residents aged ≥1 year in selected households were examined for TF and TT. Information on WASH access in surveyed households was also collected through questioning the household head and direct observation.

Results
A total of 419,858 individuals were enumerated in 131 EUs, of whom 396,134 (94%) were examined, 54% being female. Age-adjusted EU-level prevalence of TF in children aged 1–9 years ranged from 0.15% (95% confidence interval [CI]: 0.0–0.4) to 37.5% (95% CI: 31.1–43.7). The TF prevalence was <5% in 73/131 (56%) EUs. The EU-level age- and gender-adjusted prevalence of TT unknown to the health system among people aged ≥15 years ranged from 0.001% (95% CI: 0.00–0.02) to 2.2% (95% CI: 1.1–3.1) with 37/131 (28%) EUs having a prevalence <0.2%. Only 48% of all households surveyed had access to improved water sources for drinking. Approximately 96% of households did not have an improved latrine.

Conclusion
Oromia is on the path towards elimination of trachoma as a public health problem.

 a0928-6586, 1744-5086